Chief Executive Officer
Executive Chairman of DHK Pharma, Inc., which he founded in 2007. He has over 25 years’ experience in global pharmaceutical commercialization. Mr. Kim’s therapeutic experience includes infectious diseases, oncology and hospital medical devices ranging from wound care to aesthetic products. In his marketing career, he worked with senior executives and scientists at Roche, Pfizer and Novartis, developing a unique strategic approach to a therapeutic franchise development with over $1B in investment. He has led commercial and scientific teams in over a dozen due-diligence efforts, from new product acquisition to life-cycle management.
He currently serves on the board of Gordian Biotech.
Mr. Kim formerly was President and Publisher of Elsevier Oncology from 2008 to 2011, working with an impressive list of US-based key opinion leaders and executing a variety of tactical programs for educating medical professionals both in the US and abroad.
Prior to 2008, he was Vice President of commercial operations at Cytogen Corporation, overseeing their oncology specialty sales force, marketing and business development activities.
He holds a BS degree in psychology from Virginia Commonwealth University and an MBA from Saint Joseph’s University in Philadelphia, Pennsylvania. He has also completed advanced executive training at Tuck School of Business at Dartmouth College and the Wharton School of Business at the University of Pennsylvania.